home / stock / ancn / ancn quote
Last: | $ |
---|---|
Change Percent: | 1.17% |
Open: | $1.35 |
Close: | $1.295 |
High: | $1.35 |
Low: | $1.29 |
Volume: | 9,823 |
Last Trade Date Time: | 02/12/2020 04:40:05 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $1.35 | $1.295 | $1.35 | $1.29 | 9,823 | 02-12-2020 |
$ | $1.34 | $1.28 | $1.34 | $1.2608 | 24,313 | 02-11-2020 |
$ | $1.32 | $1.33 | $1.36 | $1.3001 | 11,753 | 02-10-2020 |
$ | $1.31 | $1.29 | $1.36 | $1.29 | 4,394 | 02-07-2020 |
$ | $1.26 | $1.29 | $1.35 | $1.26 | 33,402 | 02-06-2020 |
$ | $1.3335 | $1.30 | $1.4196 | $1.30 | 22,506 | 02-05-2020 |
$ | $1.26 | $1.27 | $1.3427 | $1.26 | 21,992 | 02-04-2020 |
$ | $1.345 | $1.295 | $1.345 | $1.2669 | 14,727 | 02-03-2020 |
$ | $1.2899 | $1.28 | $1.3475 | $1.275 | 14,952 | 01-31-2020 |
$ | $1.30 | $1.2872 | $1.30 | $1.25 | 18,676 | 01-30-2020 |
$ | $1.32 | $1.345 | $1.3607 | $1.31 | 7,282 | 01-29-2020 |
$ | $1.31 | $1.35 | $1.39 | $1.31 | 6,382 | 01-28-2020 |
$ | $1.39 | $1.322 | $1.45 | $1.31 | 61,717 | 01-27-2020 |
$ | $1.52 | $1.43 | $1.55 | $1.40 | 23,236 | 01-24-2020 |
$ | $1.46 | $1.48 | $1.4899 | $1.452 | 19,013 | 01-23-2020 |
$ | $1.47 | $1.47 | $1.5764 | $1.4603 | 18,949 | 01-22-2020 |
$ | $1.62 | $1.50 | $1.6423 | $1.50 | 30,289 | 01-21-2020 |
$ | $1.47 | $1.58 | $1.6421 | $1.47 | 42,168 | 01-20-2020 |
$ | $1.47 | $1.58 | $1.6421 | $1.47 | 36,039 | 01-17-2020 |
$ | $1.43 | $1.51 | $1.69 | $1.43 | 161,168 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Chemomab Therapeutics Company Name:
ANCN Stock Symbol:
NYSE Market:
Anchiano s hareholders approve all resolutions at shareholder meeting The merged company is expected to receive approximate gross proceeds from the private financing of $ 45 .5 million, which will be used to a dvance the Chemomab...
Are These 5 Biotech Penny Stocks Worth Watching? With the extraordinary times we live in, Covid has resulted in a large investor focus on biotech penny stocks. Within the stock market, there’s no shortage of interesting biotech companies to choose from. In 2021, it’s best ...
NEW YORK, NY / ACCESSWIRE / February 3, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in N...